Ann Lab Med.  2014 Jan;34(1):80-84. 10.3343/alm.2014.34.1.80.

Ataxia-Telangiectasia with Novel Splicing Mutations in the ATM Gene

Affiliations
  • 1Department of Neurology, Gyeongsang National University School of Medicine, Jinju, Korea.
  • 2Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. changski@skku.edu
  • 3Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 4Department of Neurology, Soonchunhyang University Hospital, Soonchunhyang University School of Medicine, Seoul, Korea.

Abstract

No abstract available.


MeSH Terms

Adolescent
Ataxia Telangiectasia/*genetics
Ataxia Telangiectasia Mutated Proteins/*genetics
Base Sequence
Chromosome Inversion
Chromosomes, Human, Pair 14/genetics
Chromosomes, Human, Pair 7/genetics
DNA Mutational Analysis
Female
Humans
Karyotyping
Magnetic Resonance Imaging
Mutation
RNA Splicing
Translocation, Genetic
Ataxia Telangiectasia Mutated Proteins

Figure

  • Fig. 1 Bilateral ocular telangiectasias. (A) Right eye. (B) Left eye.

  • Fig. 2 Sagittal T1-weighted magnetic resonance image of the patient's brain. Pronounced cerebellar atrophy is evident.

  • Fig. 3 Giemsa-banded karyograms of the peripheral blood lymphocyte culture. (A) 46,XX,t(7;14)(q32;q11.2). (B) 46,XX,t(7;14)(p15.1;q11.2). (C) 46,XX,inv(7)(p1?q3?). Arrows indicate the breakpoints on each chromosome.

  • Fig. 4 Genomic DNA sequence analysis of the ATM gene in the patient and in her parents. (A) The solid arrow indicates a heterozygous A>C transition (c.3154-2A>C). (B) The open arrow indicates a heterozygous A>C transition (c.7090-2A>C).

  • Fig. 5 Molecular effects of the c.3154-2A>C mutation. (A) The cDNA sequence from a normal control, and schematic representation of normal/aberrant mRNA splicing of the ATM gene. (B) The cDNA sequence from the patient. (C) The predicted amino acid sequence (inserted nucleotides are shaded).Abbreviation: TA, thymine/adenine.

  • Fig. 6 Molecular effects of the c.7090-2A>C mutation. (A) The cDNA sequence from a normal control, and schematic representation of normal/aberrant mRNA splicing of the ATM gene. (B) The cDNA sequence from the patient. (C) The predicted amino acid sequence (deleted nucleotides are shaded).Abbreviation: TA, thymine/adenine.


Reference

1. Gatti R. Ataxia-Telangiectasia. In : Pagon RA, Bird TD, Dolan CR, Stephens K, editors. Gene Reviews. Seattle: University of Washington;1993.
2. McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep. 2004; 5:772–776. PMID: 15289825.
Article
3. McKinnon PJ. ATM and the molecular pathogenesis of ataxia telangiectasia. Annu Rev Pathol. 2012; 7:303–321. PMID: 22035194.
Article
4. Verhagen MM, Last JI, Hogervorst FB, Smeets DF, Roeleveld N, Verheijen F, et al. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study. Hum Mutat. 2012; 33:561–571. PMID: 22213089.
Article
5. Woods CG, Bundey SE, Taylor AM. Unusual features in the inheritance of ataxia telangiectasia. Hum Genet. 1990; 84:555–562. PMID: 2338342.
Article
6. Jiang H, Tang B, Xia K, Hu Z, Shen L, Tang J, et al. Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia. J Neurol Sci. 2006; 241:1–6. PMID: 16380133.
Article
7. Morio T, Takahashi N, Watanabe F, Honda F, Sato M, Takagi M, et al. Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan. Int J Hematol. 2009; 90:455–462. PMID: 19705055.
Article
8. Kang DW, Ahn SS, Jeon BS. A case of ataxia telangiectasia. J Korean Neurol Assoc. 1997; 15:895–899.
9. Song MH, Kim EJ, Sung TJ, Shin SH, Lee KH, Kim HD. A case of progressive elevation of serum gamma-GTP level in ataxia-telangiectasia. J Korean Child Neurol Soc. 2006; 14:363–368.
10. Huh HJ, Cho KH, Lee JE, Kwon MJ, Ki CS, Lee PH. Identification of ATM mutations in Korean siblings with ataxia-telangiectasia. Ann Lab Med. 2013; 33:217–220. PMID: 23667852.
Article
11. Verhagen MM, Abdo WF, Willemsen MA, Hogervorst FB, Smeets DF, Hiel JA, et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology. 2009; 73:430–437. PMID: 19535770.
Article
12. Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M, et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet. 1998; 62:551–561. PMID: 9497252.
Article
13. Stumm M, Neubauer S, Keindorff S, Wegner RD, Wieacker P, Sauer R. High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome. Cytogenet Cell Genet. 2001; 92:186–191. PMID: 11435685.
Article
14. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004; 144:505–511. PMID: 15069401.
Article
15. Laake K, Jansen L, Hahnemann JM, Brondum-Nielsen K, Lönnqvist T, Kääriäinen H, et al. Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia. Hum Mutat. 2000; 16:232–246. PMID: 10980530.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr